Information & Resources

Find information and resources to help manage your pain.

Get Help & Support

Find the tools you need to
help you manage your pain.

Get Involved

Help make a real difference to people
in the UK living with chronic pain.

About Us

Find out about Pain Concern and how
we can help you.

On Tuesday 7 July 2020, Airing Pain returns, with producer Paul Evans looking into opioid medication for chronic pain. Tune in as he speaks to two world-reknowned pain specialists, a GP and a chronic pain patient who maganged to reduce her medication, looking into the opioid addiction crisis, the rates of prescribing and how effective these drugs really are for dealing with chronic pain.

Watch the trailer above for more details

Contributors:

  • Dr Srinivasa Raja, Professor of Anaesthesiology and Critical Care Medicine and Neurology at the Johns Hopkins University School of Medicine, Maryland, USA
  • Dr Cathy Stannard, Consultant in Pain Medicine and Pain Transformation Programme Clinical Lead for NHS Gloucestershire Clinical Commissioning Group
  • Louise Trewern, Vice Chair of the Patient Voice Committee at the British Pain Society
  • Dr Jim Huddy, Cornwall GP and Clinical Lead for Chronic Pain at NHS Kernow Clinical Commissioning Group.

Available to listen on our website, or download from wherever you get your podcasts.

In Spring of 1995, the first Newsletter of the Pain Concern (UK) Lothian Group was issued. The newsletter was printed at a volunteer’s house on ordinary copy paper and had articles from clinicians and patients. Demand grew and by Issue 22 (Autumn 2000) it was Pain Concern News and had contributions from around the UK. Issue 26 (December 2001) was the first to be professionally laid out and printed using our partners, Creative Link, in North Berwick. Glossy paper and a touch of colour on the front page warranted a rebrand and the title Pain Matters was born. Issue 41 was the first in full colour with an article by regular contributor Margaret Graham on how visualising colours affect mood. Issue 50 was a landmark with a then radical article on medicinal cannabis and a brazen close-up of a cannabis plant on the front cover. We now regularly invite clinical teams to guest-edit their own edition, so readers get news direct from the coalface of pain management. There is a digital edition, an email supplement and hardcopies are distributed to pain clinics across the UK. It has come a long way from a volunteer printing a few dozen copies in their house. Thank you for reading and supporting Pain Matters!

Our new issue, Pain Matters 75, is due to come out on Monday 25 May. As this issue marks the twenty-fifth anniversary of the very first Pain Concern (UK) Lothian Group newsletter, later to become the Pain Matters we know today, we have gone back to where it all started. The Lothian Group was a patient support group set up by members of the Astley Ainslie Hospital pain management programme, so it seems appropriate that this issue is being guest-edited by the Chronic Pain Management Service from NHS Lothian, based at the same hospital.

This issue’s theme is compassion-focused therapy, with the team showing the different ways they use compassion as part of a holistic pain management approach. A lot has changed in the world since our last issue, and here at Pain Concern, we think that compassion is something which we could all use more of at the moment.

Buy or subscribe at painconcern.org.uk/product-category/pain-matters.

Or why not try our digital version, available at pocketmags.com/pain-matters-magazine.

Also, our Pocketmags sale is still running, so if you buy an annual subscription by midnight on the 25th May, you will also be able to choose any 4 back issues. In total, that is 8 magazines for the price of a one year’s subscription – only £6.99!

Visiting the forefront of research into pain conditions

As research for a Covid-19 vaccine is a priority for the scientific community, this edition of Airing Pain focuses on the roles of researchers, and in particular the many disciplines that come together to increase the understanding, and therefore the management of chronic pain.

Available to listen to from 5 May 2020 here or download from wherever you get your podcasts.

Watch the trailer below:

WE RECOMMEND READING THIS ARTICLE IN CONJUNCTION WITH OUR LEAFLET, ANTIDEPRESSANTS


Many people living with chronic pain are daunted by the prospect of long term or even permanent drug therapy. What are these drugs, are they safe and how do they work? Concerns such as these can stop people persevering with medicines that may offer a real, life-enhancing solution to their condition. Dr Mick Serpell explains how amitriptyline works and gives reassurance about the side effects that you might experience, especially in the early stages

The aims in managing chronic pain are obviously to relieve or to reduce the pain as much as possible, but this is not always achieved to the level patients would wish. Just as important then, is to improve overall quality of life by improving physical function, sleep, mood and psychological function. There are four main approaches to pain management:

1) physical therapy (physiotherapy, acupuncture, TENS (transcutaneous electrical nerve stimulation), etc.
2) drug therapy
3) regional analgesia (injection of drugs around nerves, joints or other tissues)
4) psychological therapies (techniques which improve coping with the pain).

Two types of pain

Doctors describe pain as either nociceptive (tissue damage), neuropathic (nerve damage), or a combination of the two. It is important to distinguish between the two types of pain, as they respond to different medicines. Nociceptive pain is the most common form of chronic pain, and examples include mechanical low back pain and degenerative or inflammatory joint pain. Although these pains may begin as purely nociceptive, over time there may be changes within the nervous system. Neuropathic pain often results from nerve damage that makes the nerve overactive. Therefore the drugs used for neuropathic pain are aimed at stabilisation or ‘calming’ of these nerves. Perhaps it should be no surprise, then, that drugs used in other conditions where nervous tissue is overactive or ‘excited’, such as epilepsy or depression, have turned out to be useful medicines for chronic pain.

Drug therapy

Conventional painkillers such as codeine and ibuprofen are used for nociceptive pain. They are often not effective for neuropathic pain. Most of the drugs used for the relief of neuropathic pain were originally developed to treat different conditions. For instance, amitriptyline is an antidepressant drug but is now used much more commonly for pain than for its original use. The situation is the same for some anticonvulsant drugs, such as gabapentin, which are used more frequently for neuropathic pain than epilepsy.

Change your lifestyle

Always remember that the medicine alone will not be enough. While drug therapy can play a role in the management of pain, changing your lifestyle (such as building up your fitness and getting more exercise), as well as learning to manage and cope with your pain better, are also vital to a successful outcome.

General principles of drug therapy

Your doctor will start you off at a low dose of your medicine and this is increased up to a suitable dosage and taken for sufficient duration until you obtain noticeable pain relief (or experience severe side effects). This procedure of increasing the dose step by step while monitoring the effect is called ‘titrating the dose’. If there is insufficient pain relief or troublesome side effects, the drug will be stopped. Your doctor is likely to gradually wean you off the medication over several weeks, in order to avoid potential sudden withdrawal effects. If you get partial, but inadequate pain relief, sometimes your doctor will add in another different drug, because ‘combination’ therapy can be more effective for pain than single drug therapy. However, there is an increased risk of side effects when more drugs are taken.

Once you are on the right dose and drug combination, then you may continue on the medication indefinitely. However, this should always be reviewed by you and your doctor, every three to six months. It may be that you decide the medications are no longer helping enough, or that you are now experiencing problematic side effects. In this case you should wean yourself off the medications gradually (one at a time) to ensure they are still benefitting you.

Most doctors agree that medication for chronic pain should be taken regularly ‘round the clock’ rather than ‘as required’ for breakthrough pain. It is easier to keep pain at bay rather than trying to chase it after it has been allowed to get out of control.

Antidepressants

The tricyclic antidepressants, such as amitriptyline, are the ‘gold standard’ for neuropathic pain as they are the most effective and best-known drugs for this condition. They can also be useful for chronic nociceptive pain, especially if there is a neuropathic component to it. They appear to work in the nervous system by reducing the nerve cell’s ability to re-absorb chemicals such as serotonin and noradrenaline. These chemicals are called neural transmitters. If they are not reabsorbed they accumulate outside the nerve cell and the result is suppression of pain messages in the spinal cord.

All in the mind?

The way antidepressants give pain relief is completely separate from the anti-depressant effect. The dose required for treating depression is much higher (150-250 milligrams (mg) a day) rather than the doses used for pain relief (25-75 mg/d). Amitriptyline also works in patients who are not depressed. Also, there are over twenty different antidepressant drugs available for treating depression, but only a small number can also be effective pain killers.

It is important that the patient is given a full explanation of the rationale for using antidepressant therapy. It is not the case that the doctor believes your pain is due to the depression. So do not think that you are not being taken seriously, or that the pain is ‘all in your mind’.
Depression can occur with chronic pain, it is usually ‘reactive’ or in response to the pain, suffering and loss of function, and often improves as the chronic pain improves. However, if severe, it may require simultaneous treatment with other antidepressant therapies such as psychology techniques or another antidepressant drug.

Starting amitriptyline

One in four people will get significant pain relief with amitriptyline. This is regarded as an excellent result for chronic pain conditions. It is started at a low dose (10 or 25 mg a day) and gradually increased in 10 or 25 mg increments each week up towards 75 mg if side effects are tolerable. Your doctor may advise you to go higher than this dose. The tablets are small and difficult to cut in half, and will often produce numbness of the tongue due to a local anaesthetic effect, but it is available as a syrup. It is better to use the syrup if small increases of dose are required during the titration (dose build-up) phase.

Keep taking it!

You may notice pain relief as quickly as two weeks after starting, but often amitriptyline requires to be taken for six to eight weeks at the optimal dose level before one can say the drug has been given a fair trial. Many people stop taking the medicine because they experience side effects early on but do not feel any benefit. However, if you can persevere, you will often get tolerant to most of the side effects after a few days to weeks and you may then start noticing the benefits of the medicine.

Although there are a number of side effects associated with amitriptyline most of them are extremely uncommon. The most common ones, experienced by only 5-15% of people, include dizziness, drowsiness, dry mouth, nausea and constipation. These side effects are generally harmless and, provided you do not exceed the dose, will not cause any damage. Most people find they adapt to these and eventually they go away. Amitriptyline is not addictive but if discontinued, it should be withdrawn slowly over several weeks in order to avoid withdrawal symptoms of headache and malaise. Your doctor can advise on this.

Not for everyone

Your doctor will not prescribe this drug for you if you have had an allergic reaction to amitriptyline or related drugs; a recent heart attack; or recent administration of drugs that can interact with amitriptyline.

When should I take it?

Amitriptyline is long acting, so only needs to be taken once a day. As one of the most common side effects is drowsiness, it is best to take it one to two hours before bedtime. This effect can be particularly useful if you suffer lack of sleep from your pain. Sometimes there is a ‘morning after’ type of hangover feeling, but this usually wears off with time. Occasionally amitriptyline can cause insomnia; if this happens it is better to take it in the morning.

Worth trying

If side effects are a problem, there are other similar drugs (for example, nortriptyline, imipramine, and now duloxetine) that are worth trying as they are nearly as effective, and often have less side effects,. Many of the patients I have seen have stayed on amitriptyline for years and say that it has transformed their lives. When dealing with pain, it is worth giving drug therapy a chance. Best results are achieved in combination with the non-drug therapies mentioned above. It is important to work with your doctor to try the different approaches so that you find the particular approach that is right for you. The optimal result is rarely complete pain relief. It is often that which brings you the best balance of pain relief, improved function, and minimal side effects, to give you the quality of life that you and your doctor both want.


Further Resources


Mick Serpell is a Consultant in Anaesthesia & Pain Medicine for Greater Glasgow & Clyde NHS, and Senior Lecturer at Glasgow University. 

If you would like to know more about the sources of evidence consulted for this publication please click here.

Amitriptyline © Michael Serpell. All rights reserved. Revised April 2019. To be reviewed April 2022. First published April 2013.

Exploring neuropathic pain and the various ways it can be managed

Understanding the differences between neuropathic and non-neuropathic pain, and the varied responses they demand. In this edition of Airing Pain, Paul Evans investigates the ideas behind Pain Management Programmes, and highlights the importance of the patient in shaping their own treatment.

Internationally recognised Professor Srinivasa Raja speaks to Paul about the differences between nociceptive and neuropathic pain, as well as the complexities of chronic pain and its management.

Consultant Clinical Psychologist, Dr Clare Daniel examines the psychological and social components of chronic pain. She discusses the important role of the cognitive behavioural model in Pain Management Programmes.

Paul speaks to lead physiotherapist Diarmuid Denneny about the importance of the patient in determining the appropriate response to their pain, by taking into account their life and personal aspirations.

Finally, Cameron Rashide, a patient with neuropathic pain among other conditions, speaks of the pain management technique ‘pacing’ and how she has learnt to manage her pain through pushing herself ever so slightly outside her comfort zone.

Issues covered in this programme include: After a stroke, post-herpetic neuralgia, shingles, post-surgical pain, brain signals, emotions, exercise, loss of sensation, mindfulness, nervous system, neuropathic pain, nociceptive pain, numbness, pacing, psychology, tissue injury and trigeminal neuralgia.


Contributors:

  • Dr Clare Daniel, Consultant Clinical Psychologist, Buckinghamshire Healthcare NHS Trust
  • Diarmuid Denneny, Physiotherapy Lead at the National Hospital for Neurology and Neurosurgery Pain Management Centre in London
  • Professor Srinivasa Raja, Johns Hopkins School of Medicine, USA
  • Cameron Rashide, patient who lives with chronic pain.

More Information:

Pain Concern and Covid-19

With the current pandemic causing uncertainty and confusion around the world, we will continue to keep our followers and supporters updated with any news relevant to people living with pain, their friends, family and healthcare professionals. We will strive to do our best to supply all our resources (magazines, leaflets, podcasts) while we can, assuming it is safe for our staff and volunteers to do so.

Unfortunately, we have had to make the difficult decision to suspend our telephone Helpline support for the immediate future. The Helpline is staffed by volunteers, some of whom have their own health issues. Given the current situation, we are not able to provide the Helpline service in the way that we would wish to.

People seeking support with their pain may continue to use our online community Health Unlocked Forum at healthunlocked.com/painconcern or contact our email help service at help@painconcern.org.uk.

We will strive to reinstate the service as soon as it is safe and viable to do so. But for now, stay safe, stay home, wash your hands and we will still be here on the other side, providing resources, support and advocating for those living with pain.

Further resources:

Pain specialists from around the world have reviewed ways in which people with chronic pain can continue to be helped using modern technology despite pain treatment centre across the world having closed their doors. Publishing their results in the medical journal Pain, they point out that telemedicine and e-health, as remote medicine is called, is not a new concept but the Covid-19 pandemic has made it ‘imperative’ that patients with chronic but non-urgent conditions can access the support they need. Patients with chronic pain will be adversely affected by the pandemic even if they do not become ill with Covid-19 as their healthcare becomes disrupted. This can lead to their condition worsening with accompanying suffering and depression.

Simple solutions could involve nothing more than a phone call or text messages. Video conferencing is now widely accessed via apps such as FaceTime and Zoom. There are already systems in place in some centres for clinical evaluation remotely. Self-management options are available online and many of these have been formerly evaluated in clinical trials. They have shown at least some benefit in reducing pain, disability and distress. Commercially available options exist, but the authors warn that there is often no quality control over content and the buyer should beware. They also warn that because of the fast implementation of these new methods of consulting in response to the Covid-19 crisis there may be unforeseen downsides. However, lessons will be learned and, after the pandemic, it is likely that many of these new ways will continue to be used for people in pain who need help.

The full text of the paper is available at journals.lww.com/pain/Citation/publishahead/Managing_patients_with_chronic_pain_during_the.98431.aspx

ARE YOU AN ADULT WITH CHRONIC PAIN?

Our friends at the University of Warwick Psychology Department’s Sleep & Pain Lab are looking for volunteers to complete a short online questionnaire for their WITHIN study, which aims to help explain distress and disability in chronic pain.

If you are interested and feel like you could help, or if you would just like some more information, get in touch using the contact details on the attached poster or visit the WITHIN homepage for more details on the study itself.

The terms endemic, epidemic and pandemic are used to describe the way diseases (not just infections) affect populations of humans or animals. The terms epidemic and pandemic have a very similar meaning: an epidemic is a rise in the number of new cases of a disease in a population; a pandemic is simply an epidemic that occurs over a wide geographical area. The point at which an epidemic becomes a pandemic is the point at which experts start calling it a pandemic. Not all epidemics become pandemics. Some epidemics are limited by geographical boundaries especially in remote rural population who do not travel much, or they just peter out.

When a pandemic or epidemic dies down (they always do) the disease may become endemic. This means that it is always present in the population, usually causing milder disease in most people. This endemic situation is what we experience with seasonal flu, coughs and colds, sore throats, viral gastroenteritis etc. The disease fluctuates and people may notice that ‘there is a lot of it about’ but it never really causes a true epidemic – it just grumbles on year after year.

So why don’t pandemics just go on and on? Humans, like other animals, become immune to the infection. When you have a sore throat you will notice that your ‘glands are up’. If you feel your neck at the corner of your jaw, you will notice a marble-sized hard structure on either side. These are your submandibular lymph nodes (or lymph glands) and they are full of B cells that respond to any foreign material (such as a virus) by producing proteins called antibodies that attach to the intruder and allow the body to get rid of it. When you are fighting an infection the glands become swollen and painful, but the best bit is that the B cells remember the bug and the next time it comes along they are ready to produce a big surge of antibodies to kill it.

This is what being immune is. The antibodies are particular to the bug that provoked them, so being immune to one virus does not mean you are immune to another. Vaccines work by injecting a dead or a live infection that stimulates immunity, but not disease, and so makes the B cells get ready for the real thing. Only twice have vaccines been used to eradicate a disease for ever: smallpox and the cattle plague known as rinderpest. However, for most diseases the bacterium or virus lives in the population, with there being enough immunity in the population (through vaccination or natural infection) for it to be held in check with relatively mild disease in a small number of people. Scientists have borrowed the veterinary term for this state and refer to it as herd immunity.

What does all this mean for Covid-19? The virus is a member of a common family of viruses called coronaviruses. This newly discovered virus is called SARS-cov-2. That seems complicated but it isn’t: ‘SARS’ stands for severe acute respiratory syndrome, ‘cov’ stands for coronavirus, and as this is the second coronavirus to cause a severe acute respiratory syndrome: SARS-cov-2. That is the name of the virus, but the name of the disease it causes is Covid-19 (Coronavirus disease 2019). Why the pandemic? Well, one theory is that SARS-cov-2 was endemic in animals not causing any trouble, but it jumped across to humans and found it could multiply and spread very rapidly in human tissues. As this is a new virus for humans our lymph glands are not prepared and the virus was able to multiply quickly and spread, sometimes without causing disease. So it started as an epidemic in China, and quickly became a pandemic.

As herd immunity grows and especially when we develop a vaccine then Covid-19 will hopefully become endemic in the world population. In this future state, occasional people who are already unwell will become seriously ill but, if it does become endemic in the population, mostly it will be just another thing we notice in winter as we cough in a bus queue and remark that ‘there is a lot of it about’.

With the current pandemic causing uncertainty and confusion around the world, we will continue to keep our followers and supporters updated with any news relevant to people living with pain, their friends, family and healthcare professionals. We will strive to do our best to supply all our resources (magazines, leaflets, podcasts) while we can, assuming it is safe for our staff and volunteers to do so.

Unfortunately, we have had to make the difficult decision to suspend our telephone Helpline support for the immediate future. The Helpline is staffed by volunteers, some of whom have their own health issues. Given the current situation, we are not able to provide the Helpline service in the way that we would wish to.

People seeking support with their pain may continue to use our online community Health Unlocked Forum at healthunlocked.com/painconcern or contact our email help service at help@painconcern.org.uk.

We will strive to reinstate the service as soon as it is safe and viable to do so. But for now, stay safe, stay home, wash your hands and we will still be here on the other side, providing resources, support and advocating for those living with pain.

Please Read This Leaflet Carefully

by Karen Havelin

Dead Ink Books, 320pp, £11.99

ISBN: 978-1911585541

Published May 2019

Review by Sarah Edwards

This novel is written from the perspective of Laura, a young woman with endometriosis. It tracks her life backwards from 2016, as a working mother in New York, all the way to 1995, when she was a teenage figure skater living in Norway. We read about Laura developing her identity, trying to fulfill her career and travel ambitions, starting (and ending) romantic relationships, and struggling with the demands of parenthood. The reverse chronology lets us appreciate how much she achieves and how far she has come, layering more insight into her personal history and background as it progresses.

Throughout this narrative of Laura’s life, the pervading thread is her struggle with endometriosis and its impact on her. Descriptions of pain and discomfort, which change over different stages of her life, are constantly interwoven. We read about the sometimes helpful, sometimes confusing, sometimes distressing medical appointments which she endures, and the additional therapies and strategies, which she tries to implement consistently, to help her to manage a ‘normal’ life. We also experience the emotional turmoil that this struggle takes her through. This ranges from from the relief and hope of a diagnosis, to the fear of the pain getting worse, to the distress of an interaction with an unsympathetic healthcare professional, and the anger that she has no choice but to live with this long-term health condition.

The story of Laura opens a window onto the challenges of trying to live a full life whilst also living with the symptoms of endometriosis. It shows us the emotional, physical and cognitive impact of having a long-term pain condition, normalising how much this struggle is present in daily life. We see clearly the struggle which Laura faces in trying to do the ‘average’ things in life, such as having a long-term relationship and working full-time, and how much of a balancing act she has daily to ensure that the pain does not flare to unmanageable levels. We also see the impact that it has on her relationships, whether family, romantic or friends.

At times, the strong descriptions of the all-consuming and debilitating nature of Laura’s pain can make for difficult reading. In its use of frequency to ensure that these descriptions are made clear (and that Laura is listened to), the book can feel a little repetitive. However, this also helps us to understand how inescapable and ever-present the pain is. We are left admiring her strength, determination and emotional resilience. This is a novel which gives real insight into the impact which a long-term pain condition has on all aspects of ‘normal’ life.

Sarah Edwards is a Clinical Psychologist at the University College London Hospitals’ Pain Management Centre, where she helps to deliver self-management support to people with abdomino-pelvic pain. She was also a co-author of Pain Concern’s Sex and Chronic Pain leaflet.

 
1 2 3 4 32
https://painconcern.org.uk/cordless-car-vacuum-cleaner-eraclean-best-handheld-vacuum/
https://painconcern.org.uk/cordless-car-vacuum-cleaner-eraclean-best-handheld-vacuum/ https://painconcern.org.uk/sex-toys-in-india-best-adult-products-online-sex-toys-store-for-men-woman/